The partnership is expected to benefit providers by offering the market an alternative solution that combines NovoPath’s deep expertise in anatomic pathology with McKesson’s best-of-breed laboratory solutions.
In addition to further extending NovoPath’s considerable presence in the anatomic pathology market, this agreement also supports McKesson’s Better Health 2020 strategy to enable better business, care and connectivity across the healthcare continuum – including laboratories throughout the country.
Delivering enhanced communications, productivity and accuracy to pathology lab professionals nationwide, NovoPath is a comprehensive workflow and reporting lab information software system specifically designed to support the unique needs of the anatomic pathology laboratory. The NovoPath solution has been installed in small, medium and large hospitals, as well as specialty practice anatomic pathology laboratories, and local, regional and national reference labs.
“We are excited about this new relationship with NovoPath, which has a track record of exceptional service and product offerings for the anatomic pathology laboratory market,” said John Yount, vice president, Lab Solutions.
Both companies look forward to providing a comprehensive anatomic pathology solution that complements McKesson’s suite of laboratory solutions.
“This partnership enables NovoPath to provide McKesson customers and the larger market with a tightly integrated anatomic pathology solution,” commented Rick Callahan, NovoPath’s vice president of sales and marketing. “This integration offers laboratories the best of both worlds; a seamless integration of a best-of-breed with an outstanding enterprise-wide solution.”